SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21
Authors:
- 29 May 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 123 (22) , 3452-3461
Abstract
Cutaneous CD30+ lymphoproliferative disease (CD30+LPD), characterized by the presence of CD30+ anaplastic large T cells, comprises the second most common group of cutaneous T-cell lymphoma (CTCL). However, little is known about the pathobiology of the CD30+ lymphoma cells, as well as the mechanisms of disease progression. Here we report that Special AT-rich region binding protein 1 (SATB1), a thymocyte specific chromatin organizer, is over-expressed in CD30+ lymphoma cells in most CD30+LPDs, and its expression is upregulated during disease progression. Our findings show that SATB1 silencing in CD30+LPD cells leads to G1 cell cycle arrest mediated by p21 activation. Using chromatin immunoprecipitation, luciferase assays, and mutational analysis, we demonstrate that SATB1 directly regulates the transcription of p21 in a p53-independent manner. Moreover, DNA demethylation on a specific CpG-rich region of the SATB1 promoter is associated with the upregulation of SATB1 during disease progression. These experiments define a novel SATB1-p21 pathway in malignant CD30+ T lymphocytes, which provides novel molecular insights into the pathogenesis of CD30+LPDs and possibly leads to new therapies. Key Points SATB1 is specifically overexpressed in the CD30+ lymphoma cells in cutaneous CD30+ lymphoproliferative disease. SATB1 promotes proliferation of CD30+ lymphoma cells by direct transcriptional repression of cell cycle inhibitor p21.Keywords
This publication has 50 references indexed in Scilit:
- High Soluble CD30, CD25, and IL-6 May Identify Patients with Worse Survival in CD30+ Cutaneous Lymphomas and Early Mycosis FungoidesJournal of Investigative Dermatology, 2012
- EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*Blood, 2011
- Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationNature Immunology, 2011
- Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencingBlood, 2011
- SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiationBlood, 2010
- Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviorsBlood, 2010
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cellsJournal of Experimental Medicine, 2008
- Cytosine methylation profiling of cancer cell linesProceedings of the National Academy of Sciences, 2008
- Applied bioinformatics for the identification of regulatory elementsNature Reviews Genetics, 2004